Cargando…
Ligand-dependent EphA7 signaling inhibits prostate tumor growth and progression
The downregulation of receptor tyrosine kinase EphA7 is frequent in epithelial cancers and linked to tumor progression. However, the detailed mechanism of EphA7-mediated prostate tumor progression remains elusive. To test the role of EphA7 receptor in prostate cancer (PCa) progression directly, we g...
Autores principales: | Li, Shibao, Wu, Zhiyuan, Ma, Ping, Xu, Yinhai, Chen, Yuming, Wang, Hua, He, Ping, Kang, Zhihua, Yin, Lingyu, Zhao, Yao, Zhang, Xinju, Xu, Xiao, Ma, Xiaochao, Guan, Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5682672/ https://www.ncbi.nlm.nih.gov/pubmed/29022918 http://dx.doi.org/10.1038/cddis.2017.507 |
Ejemplares similares
-
Downregulation of EphA5 by promoter methylation in human prostate cancer
por: Li, Shibao, et al.
Publicado: (2015) -
EphA6 promotes angiogenesis and prostate cancer metastasis and is associated with human prostate cancer progression
por: Li, Shibao, et al.
Publicado: (2015) -
Ephrin Receptors (Eph): EphA1, EphA5, and EphA7 Expression in Uveal Melanoma—Associations with Clinical Parameters and Patient Survival
por: Gajdzis, Malgorzata, et al.
Publicado: (2020) -
The prognosis value of EphA3 and the androgen receptor in prostate cancer treated with radical prostatectomy
por: Duan, Xiuzhi, et al.
Publicado: (2019) -
EphA5 and EphA6: regulation of neuronal and spine morphology
por: Das, Gitanjali, et al.
Publicado: (2016)